After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...

Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a ...

As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

With no drugs with different mechanisms for schizophrenia for ... i.e. both positive (delusions and hallucination) symptoms and negative (social withdrawal and apathy). Emraclidine, meanwhile ...

Shares in AbbVie have slumped after a pair of failed phase 2 trials for emraclidine, a schizophrenia drug ... measured using the Positive and Negative Syndrome Scale (PANSS) total score.

Learn more about whether ACADIA Pharmaceuticals Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Using diagnostic labels for people with mental health issues is on the rise, but this can sometimes hinder rather than help, psychologists warn.

We recently published a list of 15 Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years. In this article, we are going ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers have identified a deficit in contrast perception in people with schizophrenia. According to a ...

The anti-vaccine sentiment that Robert F. Kennedy Jr. has encouraged was too much even for a Republican senator.